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ABSTRACT 
 
The actions of the immune system are highly dependent on locality for development, memory 
imprinting, surveillance and effector functions. Migratory processes are therefore essential for 
maintaining immunological integrity of multicellular organisms.  Given this complexity, it is 
perhaps not surprising that some of the functions employed by the immune system also are 
found in various other situations where a need for cellular motility is required such and 
angiogenesis and organogenesis.  
To examine the complexity and distribution migratory markers we employed a hypothesis 
generating approach by investigating levels of chemokine receptors in different immune cell 
subsets in various tissues (Paper I and II). In order to evaluate how these markers change 
during development we focused our attention on bone marrow derived cells and compared 
them with mature leukocytes in bone marrow and peripheral blood.  We were able to 
determine how different migratory markers change with increasing cellular maturity and were 
also able to determine differences between different patient groups.              
We also addressed the expression of transcription factor Aire in bone marrow from both mice 
and humans (Paper III). In a series of experiments we examined expression pattern and 
regulation of genes related to Aire expression. We found that the transcription of Aire is 
present in peripheral dendritic cells in mice and down regulated in response to IFN-γ 
stimulation. We also demonstrated how Aire
-/- 
KO mice have an altered composition of 
peripheral myeloid cells. 
Finally, we investigated how IgE antibodies towards a carbohydrate epitope αGal arise in 
both patients with cat allergy and patients with macroparasitic infections (Paper IV).  We 
showed how the two patient groups differ in serological profile and how such serological 
testing can be improved by using component based antigen techniques.   
In summary, the thesis aims to contribute to how migratory capacity is altered with 
development and disease state by a combination of different laboratory and analytical 
techniques.  
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 1 INTRODUCTION 
1.1 THE IMMUNE SYSTEM 
The cells, molecules and organs that defend the organism from pathogens are commonly 
referred to as the immune system. It is composed of a wide variety of cells and structures 
that have coevolved with our environment and surrounding pathogens. Evolutionary 
pressure and generation time are helpful in understanding how the immune system has 
evolved. Many bacterial pathogens have a generation time as short as 20 minutes whereas 
humans can live for more than a hundred years. The passing of each generation introduces 
slight changes to the genome. As a consequence, a human of a hundred years faces 2.6 
million generations of the same bacteria during a lifetime.  Considering the endless possible 
genome combinations it is remarkable that the immune system can recognize and protect 
against potentially harmful evolutionary events.  
The immune system also faces other challenges. Parasites have longer generation time than 
other microbial pathogens and one single parasite can persist several decades. Their 
genome size can be comparable with vertebrae species meaning they can employ more gene 
products that frequently are used to evade immunity. Thus, the immune system needs to be 
able to counter different types of pathogens. To this end certain the immune system has 
developed ways to identify and eliminate the potential treats. The way in which this is 
achieved depends highly on the branch of what is referred to as the innate immune system 
and the adaptive immune system     
 
1.2 INNATE IMMUNITY 
The first line of host defense consists of physical barriers like skin and mucosal membranes 
covering the body. These barriers prevent pathogens to establish a foothold by a combination 
of physical and chemical hindrance. As a wound opens, the innate immune system provides a 
second line of defense, protecting from further damage.   
1.2.1 The myeloid linage 
The innate immune system contains cells of myeloid origin and is the oldest and most 
conserved part of the immune system. Myeloid cells develop in the bone marrow from a 
common progenitor, CMP (Common Myeloid Progenitor) which in turn is derived from 
HSCs (hematopoietic stem cells). CMPs can give rise to polymorphonuclear cells, 
monocytes, macrophages and dendritic cells [1]. Polymorphonuclear cells, or granulocytes, 
mainly consists of neutrophils and to a lesser degree basophils and eosinophils. 
Granulocytes are short lived with a half-life of just a few hours. They make up roughly half 
of the leukocytes in circulation and are characterized by their segmented chromatin. 
Granulocytes act as first responders in case of infection to eliminate potential treats by 
ingesting pathogens, i.e. phagocytosis, and the release of inflammatory and anti-microbial 
mediators [2].      
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Monocytes develop in the bone marrow where they are transiently retained. The bone 
marrow continuous releases monocytes into the blood stream but during infectious stimuli; 
large amounts of monocytes can be released [3-5]. Released monocytes have different fates 
but most are short lived in circulation [6]. Some cells migrate into tissue to sustain the pool 
of tissue resident macrophages. Monocytes are divided into classical, non-classical and 
intermediate monocytes. A small portion of classical monocytes develop and mature into 
intermediate from which some differentiate into non-classical monocytes [6]. The major 
phenotypical difference between these types of monocytes is their surface expression of 
CD14 and CD16 [6]. All monocyte display phagocytic properties although classical 
monocytes are rapidly recruited to sites of injury [5] and display functional plasticity with 
low levels of proinflammatory cytokine production and perform antimicrobial phagocytosis 
as well as also promote healing [7]. Intermediate and non-classical monocytes are instead 
believed to patrol the vascular endothelium and produce large amounts of cytokines upon 
activation [8].       
Macrophages are phagocytic cell present in parenchymal organs. They are specialized in 
phagocytosis but also perform specialized tasks of immune surveillance in the form of 
antigen presentation and cytokine production. Macrophages support neighboring cells and 
play a role during wound healing. The terminology M1 and M2 refers to the biased function 
of macrophages where the M1 macrophages are pro-inflammatory while M2 macrophages 
display healing and supporting properties [9]. Since macrophages have such diverse 
appearance and function in different organs they have often received distinct names in 
different organs (Kupffer cells in liver or microglia in the central nervous system). Although 
previously assumed, most tissue resident macrophages are not derived from monocytes but 
instead from cells derived from the yolk sac during fetal development [10]. However, 
monocyte derived macrophages can in many cases replace tissue resident macrophages albeit 
this appears to be less common than previously assumed [10].  
Dendritic cells comprise a diverse group of cells with distinct ontogeny from monocytes but 
like macrophages and dendritic cells can be derived from monocytes, especially during 
inflammatory conditions [11]. Human dendritic cells can be dived into plasmacytoid DCs 
(pDCs) and myeloid or conventional DCs (mDCs or cDCs). Plasmacytoid DCs differ from 
myeloid DCs both in function and appearance with eccentric nucleus and a prominent ER 
folding as well as the production of class-1 interferons [12]. pDCs are dependent on 
transcription factors IFN8 and BATF3 and lack many myeloid markers. Their main 
function appears to be support of other antigen presenting cells and to convey antigen 
presentation of viral antigens. cDCs can in turn be subdivided into two subcategories 
termed cDC1 and cDC2. The phenotypic difference of these subset is not completely 
understood but cDC1 are also dependent on IFN8 transcription factor and display 
chemokine receptor XCR1. cDC2 is the most monocyte like DCs with retained CD14 
expression and are dependent on RELB and IRF4 transcription factor [11] for development. 
cDCs are highly specialized antigen presenting cells and fundamental to bridge the innate 
and the adaptive immune system.        
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1.2.2 Innate pattern recognition 
  
Although the peripheral circulation is continuously patrolled by primarily circulating 
monocytes and neutrophils, some myeloid cells are tissue resident [13]. Macrophages and 
dendritic cells are primarily located at sites of high pathogen exposure such as the epidermis 
or the submucosal epithelium in the gastrointestinal or respiratory tract where they serve as 
“sensor cells”. Sensor cells monitor their surrounding and identify potentially harmful 
pathogens mainly through pattern recognition receptors (PRRs) which recognize evolutionary 
preserved molecular pattern in microbes referred to as pathogen-associated molecular 
patterns (PAMPs). PRRs can detect extra-cellular presence of PAMPs such as bacterial 
flagelin or lipopolysaccarid (LPS) via Toll-like receptors (TLRs), or intracellular bacterial 
presence via NOD-like receptors (NLRs) [14]. PRRs also recognize danger associated 
molecular patterns (DAMPs) which constitute molecular components released during tissue 
damage such as extracellular nuclear material or mitochondria. There are many distinct 
PRRs, however, their downstream receptor signaling typically entails NFκB and IRF 
transcription factors.  
As consequences of NFκB and IRF transcription, a cascade of cytokines and chemokines 
are synthesized and released which further activate bystander cells. Chemokines together 
with now activated endothelial cells expressing selectins attract further leukocytes such as 
additional neutrophils and monocytes. Activated myeloid cells such as macrophages and 
dendritic cell phagocyte pathogens and debris from the site of inflammation. In the 
phagocytic process of endocytosis, the plasma membrane encircles the pathogen and the 
engulfed material is internalized in vacuoles referred to as phagosomes. The acidity of the 
phagosome kills off the pathogen. The phagosomes then fuses with another vacuole termed 
lysosome containing lytic enzymes degrading pathogen-derived material even further[14]. 
The pathogen derived peptides residues are eventually presented on the cells surface via 
HLA class II (Human Leukocyte Antigen) or MHC class II (Major Histocompatibility 
Complex).  Cells expressing MHC-II are also referred to as professional antigen presenting 
cells (APCs). The APC migrate towards the T-cell zone of the draining lymph node. This 
migration follows a gradient of CCL19 and CCL21 expressed by fibroblastic reticular cells 
in the lymph node attracting APCs and naïve T-cells expressing the chemokine receptor 7 
(CCR7) [15, 16].  
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1.2.3 Antigen presentation 
 
Most infections will be cleared by the innate immune system. However, the innate immune 
system has no memory and will respond in the same manner every time a pathogen 
reoccurs. This poses a challenge since the pathogen may as previously described have 
undergone several hundred generations of cell division introducing new ways of 
sidestepping the innate defenses. In order to counteract this and maintain an effective 
response, the innate immune cells present antigens to T-cells thus activating the adaptive 
immune system that confers specificity and memory.  
HLA class II molecules are with some limitations capable of presenting an array of 
peptides, usually between 13-17 amino-acids long. Remarkably, each T-cell express 
approximately 30000 copies of the same T-cell receptor (TCR) specific for a presented 
peptide in the context of the HLA class II molecule. This is referred to as HLA class II or 
MHC-II restricted antigen presentation. HLA class II presentation is mainly restricted to 
present phagocytosed extracellular antigens [17].  
Importantly, the APC has to provide a secondary signal indicating whether the antigen 
poses a threat or not. If no such secondary signal is provided, the T-cell will become 
unresponsive even if the TCR recognizes the antigen perfectly. In contrast, if the antigen is 
recognized by a naïve T-cell in a pro-inflammatory cytokine milieu with DAMP or PAMP 
signaling, a costimulatory secondary signal (CD80/CD86) provided by the APC to activate 
the T-cell and begin clonal expansion [18]. Additionally, a third signal consisting of pro-
inflammatory cytokines are required to initiate the adaptive immune system [19].     
Another important form of antigen presentation is provided by HLA class I present on all 
nucleated cells. HLA class I presents 8-11 amino acids long peptides derived mainly from 
cytosolic proteins.  Presentation of cytosolic antigens serves a purpose both in the case of 
intracellular pathogens such as viral pathogens and intracellular bacteria but also during 
neo-antigen present during malignancies [18].  
In a special case of antigen presentation, mainly cDCs engulf large volumes of extracellular 
fluid containing debris from dead cells and soluble peptides of pathogen origin in a process 
called micropinocytosis. These proteins then escape the phagolysosome entering the 
cytosol. Thereby, extra and intra cellular pathogen derived peptides may be presented by 
the HLA class I which is referred to as cross presentation [20].   
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1.3  ADAPTIVE IMMUNITY  
The adaptive immune system is as the name suggest capable of adapting to challenges 
posed and to modify immune response if needs be. It is evolutionary much younger than the 
innate counterpart but highly conserved within vertebrate species indicating its’ importance 
for complex organisms [21].  
1.3.1 The lymphoid linage 
 
The lymphoid linage is derived from the common lymphoid progenitor (CLP) which like 
CMP is derived from HSC and comprises primarily T and B cells of the adaptive immune 
system. Cells of the adaptive branch of the immune system are able to recognize specific 
antigens through their respective receptor termed B and T cell receptors. These receptors 
share many characteristics in that they are not encoded in the germline genome but instead 
are the result of a process termed somatic recombination. During somatic recombination, the 
antigen binding receptor is assembled from a variety of gene segments. Both the B- and T-
cell receptor is composed from gene segments consisting of a variable domain (V), diversity 
domain (D) and joining domain (J). Various versions of these gene segments are randomly 
assembled to form the antigen binding receptor in what is commonly known as V(D)J 
rearrangement or somatic recombination. The process of somatic recombination is highly 
conserved trough evolution and governed by a few essential enzymes. Interference in this 
recombination process can cause severe combined immune deficiency (SCID) with negligible 
levels of adaptive immune cells [22]. Through this process the number of potential antigen 
binding receptors widely exceeds all potential protein products of the germline genome.       
1.3.2 T-lymphocytes 
 
Thymus dependent lymphocytes or T lymphocytes a derived from the bone marrow from 
CLP but undergo selection in the thymus. T–cells precursors called thymocytes egress from 
the bone marrow niche through a process which is not fully understood but sphingosine 1-
phosphate (S1P) has been implicated [23, 24]. The thymocytes lack many of the 
characteristics of mature T-cells including their antigen binding receptor (T-cell receptor, 
TCR) and either of two co-receptors termed CD4 and CD8. When thymocytes enters the 
thymic cortex their TCR start to undergo somatic recombination in a multistep process. If 
the thymocyte fails to form a functioning T cell receptor the cell will perish. Upon forming 
a T-cell receptor the cell starts to express both the CD4 and the CD8 co-receptor. The T-cell 
now needs to receive stimulus through the newly formed TCR for continued survival. This 
is achieved through interactions with thymic stroma cell which express HLA class I and 
HLA class II by which it present self-antigens. TCRs recognizing HLA together with self-
antigens provide survival signals while those cells that fail to recognize HLA succumb to 
apoptosis. This process of testing TCR function is referred to as positive selection. In the 
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medullae T-cells whose TCR form too strong of an attachment to the HLA containing self-
peptides presented by medullary epithelial cells (mTEC) are also deleted in a process called 
negative selection. These cells could otherwise become self-reactive ie. perceive the body’s 
own proteins as pathogen-derived causing autoimmunity. Many proteins are tissue specific 
and are normally only present in their respective organ. One such example is insulin 
produced β-cells in pancreatic islets. Consequently, the immune system has had to devise 
strategies to allow for negative selection of T cell reactive against such proteins. To this end 
the thymus produce a number of tissue-specific antigens (TSA) through the transcription 
factor autoimmune regulator (AIRE) in mTECs [25]. We will return to AIRE in the 
tolerance chapter.  
1.3.2.1 CD4 and CD8 
Depending on which class of MHC molecule the T-cell primarily has interacted with in the 
thymus it will express either of the two co-receptors CD4 or CD8. The TCR is what is 
called MHC restricted meaning it does not recognize antigens outside the context of the 
MHC presentation. As previously mentioned, MHC-I is expressed on all nucleated cells, 
presenting cytosolic peptides. The CD8 co-receptor only interacts with MHC-I and 
therefore CD8 T-cells can only recognize MHC-I presented peptides. In turn, MHC-II is 
expressed on APCs and only T-cells expressing the CD4 co-receptor will recognize 
antigens presented on MHC-II [26].     
During thymic negative selection, self-reacting T-cells are deleted. However, a subset of T-
cells recognizing MHC/self-antigen  is believed to be the result of a relatively high affinity 
binding of their TCR to MHC/peptide complexes yielding a subset of T cells termed 
regulatory T cells (Treg) which in contrast to normal T-cells inhibit inflammation [27]. 
T cells leave the thymus committed to either of the CD4 and CD8 subset. These cells express 
the surface marker CD45RA indicating their naïve phenotype as they have yet to encounter 
their cognate antigen in the periphery [28]. Naïve T cells will remain in circulation between 
the T-cell areas of secondary lymphoid organs and the blood searching for an APC presenting 
their cognate antigen.  
1.3.2.2 T-cell priming 
Once naïve T-cells encounter their cognate antigen presented by MHC together with the 
appropriate stimulatory co-receptor and a pro-inflammatory cytokine milieu they become 
activated and begin to undergo rapid cell division. The progeny is referred to as effector cells 
and express CD45RO. During this process the cells down regulate their expression of CCR7 
and CD62L and instead express S1PR1 which enable the cells to enter the efferent lymphatics 
and subsequently the blood circulation due to the higher concentration of S1P [29].  The 
newly formed effector cells perform different task depending on which co-receptor is 
expressed.  
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1.3.2.3 T-cell subsets 
The CD8 and CD4 co-receptor interacts with different MHC class why these subtypes have 
different target cells. The CD8 subset respond to MHC-I expressed on all nucleated cells and 
its’ function is to induce apoptosis or kill any cells which present antigens associated with 
intra cellular pathogens like viruses. The CD8 subset is because of this often referred to 
cytotoxic T-cells as they induce cell death of infected cells. 
The CD4 subset, referred to as T-helper cells is more diverse than the CD8 subset. T-helper 
cells direct immune responses and can assist other cells in intracellular killing of 
phagocytosed pathogens or induce class switching in B-cells. The different T-helper subsets 
also secrete cytokines which can both amplify and suppress immune responses.     
1.3.2.4 T-cell phenotyping based on chemokine receptor expression.  
CD4 T-cells consist of several subsets. Interestingly, it has become apparent that T helper cell 
subsets, defined by their cytokine production, exhibit distinct signatures of chemokine 
receptors[30]. Thus it has become increasingly common to phenotype lymphocyte subsets 
based on their chemokine receptor expression[31]. Naïve T-cells home to secondary 
lymphoid organs they express CCR7, CD62L and CD45RA. Some effector subsets referred 
to as central memory T cells (TCM) also home to lymph nodes and express CCR7, CD62L. 
Since they have encountered their antigen they express CD45RO.   TCM express low levels of 
cytokines and are believed to represent a pool of primed T cell with propensity for subset 
specific cytokine production upon antigen reencounter [32]. Other effector T-cell done not 
home to secondary lymphoid organs and is hence devoid of CCR7 and CD63L expression but 
instead express chemokine receptors for tissue homing.  For example, CCR7
-
 CD45RO is 
referred to as effector memory T-cells or TEM [33]. It was previously believed that TEM in 
some cases revert to a naïve-like phenotype expressing CD45RA in the CD8 compartment 
termed TEMRA [33]. However, the TEMRA have been shown to terminally differentiated [34].    
Distinct CD4+ T-cell subsets also differ in their ability to produce cytokines and facilitate 
immune responses depending on the type of pathogen they have encountered. The TH1 cells 
secrete IFN-γ and other cytokines which assist phagocytic cells in intracellular killing of 
pathogens while TH2 cells secrete IL-4 secreted to evoke a class switch by B-cell to produce 
IgE important for defence against macroparasites. TH17 cells instead produce IL-17 important 
for neutrophil driven responses important in fungal infections. These subset where initally 
defined by their cytokine production although it has become increasingly accepted that these 
cells also differ in chemokine receptor expression. In this manner TH1cell has been shown to 
preferentially express CXCR3 while TH2 express CCR4 and TH17express CCR6 [35].  
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1.3.3 B-lymphocytes 
 
B-cells, like T-cells, are adaptive immune cells that also undergo V(D)J gene rearrangement. 
The formation of the B-cell receptor (BCR) vary slightly from that of the T-cell receptor  in 
that the B-cell receptor will undergo second turn of  somatic recombination if the formation 
of the receptor is unproductive. Unlike the TCR, which undergo development and positive 
and negative selection in the thymus, BCR is not MHC restricted. Thus, B-cells do not 
undergo positive selection which instead increases the necessity for negative selection to 
delete self-reacting clones. If the BCR bind antigen in the bone marrow the B-cells can 
undergo additional gene rearrangements to reform the BCR in order to escape deletion. As 
the BCR is formed the B-cell exit the bone marrow although not fully mature. The B-cell will 
undergo further maturation is now exposed to all self-antigens in the periphery. If its cognate 
antigen is encountered without the presence of inflammation the cell will perish. Immature B-
cells eventually migrate to the spleen where they compete to enter B-cell follicles where they 
will mature into functioning B-cells.  
 
1.3.3.1 B-cell priming 
 
The naive B-cell will migrate to the B-cell follicles of lymph nodes or the spleen but 
instead of using CCR7 naïve B-cell express the chemokine receptor CXCR5. The B-cell 
follicle is constantly exposed to antigens brought in by the afferent lymphatics and contains 
follicular dendritic cell and marginal zone macrophages that capture incoming antigens. 
Rather than degrading the antigens, they are instead presented intact to naïve B-cells. 
Binding of an antigen will cause internalization of the BCR:antigen complex whereby the 
antigen is degraded and presented via the MHC-II. When naïve B-cells encounters their 
antigen they begin to express CCR7 migrating toward the T-cell zone.  The B-cell needs 
further support from a follicular T helper cell (TFH) to become activated.  The TFH is a 
subset of CD4 T lymphocytes that instead of leaving the secondary lymphoid organ upon 
priming migrate toward the B-cell follicle by induced expression of CXCR5 and thereby co-
localizing the two in the marginal zone of the B-cell follicle. Here the B-cell present the 
antigen to the T-cell via the MHC. If the TFH recognize the antigen the B-cell presents it will 
get licensed by the T-cell to become activated and begin clonal expansion and further 
differentiation. Additionally, B-cells can be activated in a T-cell independent manner as a 
result of multivalent BCR bonding causing crosslinking of adjacent BCRs. Since the antigen 
needs to display repetitiveness it is common that these antigens constitute polymers found in 
bacteria, plants or parasites.    
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1.3.3.2 Affinity maturation, antibodies and class switch   
 
The B-cell receptors have a similar antigen binding structure as the T-cell receptor and 
similarly have the capacity to bind virtually any antigen. It is made up of two heavy chains 
and two light chains to form a “Y”- like structure. While the TCR is in need of proximity to 
exert effect through the TCR, the BCR can be secreted in a soluble form of the B-cell 
receptor termed antibody. Whereas the variability and specificity of the B-cell receptor is due 
the same V(D)J gene rearrangement as the T-cell receptor, the antigen binding site can further 
point mutate to strengthened affinity for the antigen can be formed in a process known as 
somatic hyper-mutation or affinity maturation [36].  
Naïve and newly activated B-cell express antibody class IgM and IgD. During maturation B-
cells form germinal center in which they are continually dependent on support from TFH and 
follicular DCs.  As B-cell become activated and initiate maturation to antibody producing 
plasmablasts or plasma cells several changes are introduced to the B-cell receptor. This 
includes changes to both the antigen binding domain and the heavy chain Fc domain.  The 
changes of the antigen binding domain are cause by introduction of mutation during mitosis 
during a process known as affinity maturation. High mutation rates together with a need for 
continued BCR signaling cause an increased affinity for the antigen. Additionally, CD40L 
expression and cytokines produced by the TFH may cause genomic excisions causing 
alterations in the Fc portion of the heavy chain gene by which the antibody class is altered. 
Antibodies can be produced in varietiesor classes, which have different effector mechanisms. 
This allows class switching to provide an ability to adjust immune responses depending on 
the pathogen.      
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1.4 TOLERANCE  
The immune system needs to act swiftly and eliminate treats rapidly before an infection poses 
a systemic challenge. Simultaneously, the immune response needs to be balanced and not 
cause harm or spread inflammation beyond the infected area. The concept of tolerance is that 
the immune-response is controlled and limited to actual harmful pathogens while not reacting 
against healthy tissue or other non-pathogenic material such as animal dander or gut-bacteria 
i.e. discrimination between self and non-self. As described above, the innate immune system 
needs microbe and virus specific PAMPs to initiate an inflammatory response. However, as 
the innate immune system has no memory it can by itself not judge whether an antigen is 
pathogen derived or poses a self-antigen from the affected tissue or even harmless non-self-
antigen such as foodstuffs or animal dander. The adaptive branch is therefore needed to 
control and dampen an inflammatory response.   
1.4.1 Central Tolerance   
The term central tolerance refers to processes during development in primary lymphoid 
organs (ie. bone marrow and thymus) that renders the immune system non-responsive 
alternatively actively suppressing inflammation[37].  
1.4.2 Central T-cell tolerance  
As previously described, both the B- and the T-cell receptor are assembled by somatic 
recombination to generate a diverse repertoire of receptors. For central tolerance, positive 
and negative selection is of outermost importance. The presentation of self-antigens in the 
thymus forms the basis of T-cell mediated tolerance. The TCR is tested repeatedly for 
ability to recognize self-peptide:MHC during thymic development and clones with whose 
receptor bind too strong are deleted. Many antigens are tissue specific and intuitively not 
expressed in the thymus, which would make it impossible to negatively select TCRs 
recognizing these self-antigens. However, the transcription factor AIRE, present in 
medullary thymic epithelial cells (mTEC), drives ectopic expression of such self-antigens 
for the purpose of negative selection of T cells carrying self-recognizing TCRs. The 
importance of AIRE based transcription is demonstrated in monogenetic disorder  in which 
mutations in the AIRE gene termed severe autoimmune conditions known as autoimmune 
polyendocrine syndrome – 1 (APS-1). The clinical symptoms vary but commonly include 
skin symptoms with vitiligo, alopecia and cutaneous candidiasis associated with endocrine 
disorders like diabetes mellitus hypoparathyroidism and Addison’s disease [38].  
T cells that have successfully recombined their TCR and that do not display a sufficiently 
high affinity for self-peptide:MHC complexes to be negatively selected, will form the pool of 
mature T cells. T cells that escape negative selection with a relatively high affinity for self-
peptides develop into immunosuppressive T cells known as regulatory T cells (Treg). Treg 
developed in thymus are referred to as thymic Tregs (tTreg). Tregs are antigen specific but 
instead of mediating inflammatory responses they dampen the inflammation.  
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1.4.3 Central B-cell tolerance 
Central tolerance among B-cells is less well characterized. In contrast to the TCR, the BCR 
does not undergo positive selection and therefore bind unprocessed antigens outside the 
context of the MHC presentation. Hence, the newly formed BCR could potentially bind 
antigens directly after forming. Therefore, binding of any antigen during bone marrow 
development signals self-antigen. Unlike T-cells, B-cells can undergo a second round of 
somatic recombination of the BCR light chain. If the resulting second BCR is unproductive 
or remain self-reactive the clone will be deleted. B-cell egress from the bone marrow in an 
immature, transitional state with a fixed BCR. Cells are now exposed to most antigens 
through circulation. If the BCR encounter its antigen without presence of proinflammatory 
signaling, the clone will be deleted or anergic. The immature B-cells need to reach the 
spleen for continued development in to mature B-cells.    
1.4.4  Peripheral Tolerance 
Although T-cells undergo positive and negative selection in the thymus and B-cell undergo a 
similar process in the bone marrow some self-reactive lymphocytes escape during the 
selection process. Thus there is a need to control these potentially harmful cells by peripheral 
tolerance mechanisms in the periphery.  
Peripheral tolerance occurs in mature lymphocytes which have a fully developed specific 
antigen receptor. Adaptive immune cells need co-stimulation to become activated. Cells that 
encounter their antigen without the presence of co-stimulation turn unresponsive or anergic. 
Anergy is believed to be one of the most important forms of peripheral tolerance and develop 
in absence of activated dendritic cells. However, during an ongoing inflammation, antigen 
presenting cell display foreign- and self-antigens indiscriminately. There is therefore a 
potential risk of self-antigens being presented in a manner that induces T cell activation.  
One way in which this is avoided is the presence of thymically derived Treg cells (tTreg) which 
when presented self-antigen dampen the immune response by secreting IL-10 and TGFβ. 
TGFβ can also induce naïve T-cell to develop into peripheral regulatory T cells (pTreg). These 
cells serve a similar function as tTreg although display a less stable phenotype. Tregs also 
suppress immune activation by having a high expression of the IL-2 α-chain CD25 why 
stimulating IL-2 is sequestered from effector cells in the area. Finally, Treg cells have the 
ability to use CTLA-4 to suppress the activation of APCs. The Treg phenotype is under the 
control of the transcription factor FOXP3 and patients who display mutations in the FOXP3 
gene display severe autoimmunity in a syndrome of immune-dysregulation, 
polyendocrinopathy, enteropathy and X-linked(IPEX) [39]. The generation of tTreg in the 
thymus is dependent on AIRE transcription for the production of self-antigens. Although 
previously contested, multiple examples of peripheral expression of AIRE as well as in bone 
marrow have been described. Several findings suggest that peripheral tolerance is affected in 
Aire deficiency. Immunized Aire
-/-
 mice with an exogenous antigen T cells display a 
hyperproliferative response [40]. Thus, Aire may participate in the peripheral regulation of T 
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cell activation. The expression of AIRE in humans and mice have been found in different 
myeloid cells in various tissues involved in regulation of immune responses such as in the 
thymus, spleen, lymph nodes and in the bone marrow [41]. AIRE mRNA has also been found 
in human B cells and monocytes in peripheral blood [41, 42]. The notion that Aire contribute 
to peripheral tolerance has gained traction following studies showing functional properties of 
Aire expression in the periphery [43].  
B-cells are less dependent on proximity for their adaptive response due to their ability to 
secrete soluble B-cell receptors (antibodies). Peripheral B-cell tolerance is believed to be 
induced if the naïve B-cell already has encountered its antigen in the periphery and bound it 
upon entering the T-cell area of the lymph node which in turn renders the B-cell anergic 
which leads to deletion of the self-reactive B-cell clone. The B cell typically needs to be 
licensed for switching and activation by a CD4
+
 T helper cell, in agreement with the target 
antigen. Thus, B cell tolerance is here mediated by T cell tolerance.  
1.5  LOSS OF TOLERANCE 
 
Loss of tolerance to harmless non-self-antigens is commonly known as allergy and such 
antigens are commonly present in plant pollen or animal dander. The typical allergic reaction 
of itching, redness, swelling and mucosal hypersecretion is mediated by the IgE class 
antibody [44]. The IgE antibody binds the allergen and the Fc receptor bind to FcE receptor 
on mast-cells and basophils releasing a cascade of histamine causing the inflammatory 
symptoms. Class swich to IgE is induced by IgE response is intended for combating parasitic 
infections and IgE titers are high in parasite infected patients [44]. Apart from causing 
hypersensitivity to plant and animal derived carbohydrates and proteins the allergic reaction 
may also be aimed at foodstuffs or therapeutic drugs                              .                             
 
Loss of tolerance towards self-antigens also cause autoimmune disorders. The spectrum of 
autoimmune disorder ranges from tissue specific as in the case of Addison disease or type 1 
diabetes to systemic in the case of SLE, depending on antigen location. The exact cause is 
many cases unknown but in many autoimmune disorders there is a strong link to HLA type 
indicating that certain MHC molecules are more prone to present self-antigens leading to 
autoimmunity. The clinical symptom often arises after a challenge to the immune system 
such as injury or infection. 
One disorder which bridges the gap between allergy and autoimmunity is celiac disease 
where the ingested protein gliadin attaches to self-antigen in form of the enzyme 
transglutaminase. The protein complex is then presented together on APC giving rise to 
antibodies directed both towards gliadin derived peptides as well as auto-antibodies towards 
transglutaminase[45].              
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1.5.1 Macroparasite  infections  
Macroparasites form a diverse group of multicellular eukaryotes which have the commonality 
that they are dependent on substrate from another organism like humans for survival or 
reproduction. The group includes insects and helminths as well as schistosoma species. 
Macroparasites pose a very different challenge to the immune system than viral and bacterial 
antigens. Firstly, macroparasite are typically carry a diploid genome meaning they can 
replicate through sexual reproduction unlike viruses and bacteria, Second, their spans over 
longer time periods and may persist for many years in the same host. Third, their size is in 
many cases huge compared to other challenges that the immune system faces.   
Despite their size insect, helminth and schistosoma infections often cause very limited 
inflammation and does not elicit adaptive nor innate immune responses. To counteract 
macroparasitic infection, TH2 cells elicit responses by secreting IL-4. The way in which 
parasites are initially recognized by the innate immune system is not fully understood but 
several PAMP signaling receptors, including TLR-2, has shown to recognize chitin [46]. 
Chitin is a polysaccharide which is present in exoskeletons of insects, schistosoma species 
and helminth eggs in the form of polymers. The TH2 response induced by macroparasitic 
infections are characterized by IgE antibody production. The IgE antibody elicit a release of 
histamins and lyctic enzymes when the Fc portion of the receptor crosslinks on mast cells and 
basophils thus causing a strong local immune response of vasodilatation, itching and smooth 
muscle contraction which together are believed to help in physically expulse the parasite.         
As macroparasites have a large genome and as eukaryotes they are able to mimic or even 
alter glycosylation patterns of the host [47, 48]. Many macroparasites are host specific and 
are unable to live or replicate outside the human body.  Given their long lifespan, many 
macroparasites have to employ completely different strategies for survival and immune 
evasion. An interesting example of parasite-host interaction is in how Leishmania species 
induce a TH2 response, thereby avoiding a TH1 response which for the parasite would be 
detrimental [49].         
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1.5.2 Allergy 
The term allergy describes a state of immunological memory towards an otherwise harmless 
antigen which should not evoke an immune response. Antigens which are commonly cause 
allergies are found in animal dander, food stuffs or pollen and are referred to as allergens. 
Symptoms in allergy are commonly wheezing, rhinitis, irritation, swelling, redness and 
hypersecretion.     
The prevalence of allergy has increased with improved living standards this has been 
attributed to the so called hygiene hypothesis [50] were a diminished infection burden during 
childhood result in a general TH2 skewing resulting in allergic symptoms [51, 52]. The TH2 
skewing of immune responses seen in allergy is also seen in macroparasitic infections and 
several studies have therefore suggested that the absence of parasitic infection in modern 
society could explain the increase in allergy prevalence [53, 54].  Indeed, eradication of 
parasitic infections has shown to increase prevalence of allergic symptoms [55]. However, 
the prevalence of allergic disorders within western society has not continued to rise over the 
last decades and although the hygiene hypothesis does provide correlation with the rise in 
allergic symptoms it does not provide proof of causality of allergic symptoms [56]. 
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1.6 CELLULAR TRAFFICKING 
The migratory system and the chemokine receptors described above are essential for proper 
development and function of the immune system. Immune cells are in many cases highly 
mobile and serve their function in different localities from where they developed. The 
migratory machinery employed by immune cells is also used by other cells that depends on 
trafficking and migration. For example chemokine receptors partially govern organogenesis 
during fetal development and the formation of new blood vessels. 
As previously described, myeloid sensor cells can be produced in the bone marrow but 
primarily serve their function adjacent to mucosal barrier of the gastrointestinal tract, 
airways and skin where infections are likely to occur. The development and function of 
adaptive immune cells require timely cell trafficking to enable co-localization of antigen 
presenting cells and naïve or memory type T-cells   
There is a constant circulation of immune cells 
to and from mucosal barriers, tissue, bone 
marrow and other lymphoid organs. Essential for 
this cellular trafficking are a set of selectins, 
integrins and chemokines which together govern 
cell motility.  
1.6.1 Chemokines and their receptors 
There are more than 50 known chemokines and 
approximately 20 chemokine receptors yielding a 
certain redundancy in the system with an overlap 
of chemokine receptors binding several 
chemokines [57]. The nomenclature of 
chemokines and their receptors has been 
standardized and are now classified as  C, CC, 
CXC and CX3C based on the amino- terminal 
positioning of cysteine residues [58]. However, 
many older names and acronyms are still used 
why the nomenclature can be confusing. 
 
 
Fig 1.Chemokine receptor and associated ligands 
displaying overlapping receptor-ligand affinity. 
Adapted from Griffith and colleagues, 2014 
Courtesy of Dr Malin Winerdal   
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1.6.2 Downstream regulation of chemokine receptor signaling  
 
Chemokine receptors belong to the seven transmembrane G-protein coupled receptor 
family (GPCR). The human genome carries some 800 GPCR genes of which 108 are drug 
targets encompassing some 34% of all FDA approved drugs [59] 
The GPCR downstream signaling has proven complex where several downstream signaling 
pathways are known. Generally, the intracellular domain of the receptor bind a heterotrimer 
of G-proteins (α, β, γ- subunits) during resting conditions.   
Binding of a receptor ligand will induce conformational changes of the intracellular domain 
of the receptor dissociating the α-monomer and the βγ-dimer exposing the G-protein 
binding serine or threonine residues.  Both the Gα and the Gβγ subunit may induce 
downstream signaling but in the case of chemokine receptors the Gβγ subunit is essential 
for migration.  
The Gα and the Gβγ subunits both induce second messengers such as phospholipase C-β 
(PLC-β) which convert the phosphatidylinositol (3,4,5)-trisphosphate (PIP3) to inositol 
trisphosphate (IP3) and diacylglycerol (DAG). IP3 cause release of calcium from 
endoplasmic reticulum (ER) and DAG in turn induce protein kinase C (PKC) which 
inactivate the GPCR by phosphorylation [60]. GRKs are also induced and may also 
phosphorylate the GPCR in an inhibitory feedback loop. 
PKC or GRKs readily phosphorylates the intracellular serine or threonine residues in the 
cytoplasmic tail of the ligand bound GPCR rendering the receptor inactive. The 
phosphorylated receptor readily binds β-arrestins often terminating in receptor 
internalization acting as a signal modifier at the cell surface level [61]. These β-arrestins 
bind the same sites as the Gα-subunits following phosphorylation and thereby compete for 
these binding sites. Different ligands can therefore induce so called biased agonism were 
intracellular signaling pathways vary depending on the ligand [62]. 
1.6.2.1 Heterologous desensitization 
As a consequence of the multitude of GCPRs on human cells, many downstream signaling 
pathways may overlap. This poses a considerable risk for adverse effects during 
pharmacological treatment. In one example, the GRKs may phosphorylate not just the 
stimulated receptor but also intracellular domains other GCPR whereby these are rendered 
inactive [63-66].       
 
 
 
 27 
 
1.6.3 Bone marrow egress 
 
The bone marrow provides a sheltered niche for pluripotent HSC that give rise to both 
branches of the immune system and is the origin of all leukocytes in adult humans. Several 
studies suggest that the bone marrow niche is a highly organized structure with 
compartmentalization [67]. Fully mature myeloid cells are retained in the bone marrow 
through the interactions of bone marrow stromal cells expressing stroma derived factor 1 
(SDF-1) binding chemokine receptor CXCR4. CXCR4 knockout mice display an increased 
number of circulating leukocytes. Stimulation of chemokine receptor 2 (CCR2) by its cognate 
ligand MCP-1/CCL2 cause a down regulation of CXCR4 releasing monocytes into 
circulation. It was previous suggested that expression of chemokines produced in proximity 
to peripheral inflammation could cause leukocytes to egress the bone marrow although 
studies have shown that the systemic levels of MCP-1 would not suffice [5]. Recent studies 
instead suggest that HSC in the bone marrow release MCP-1 in response to low levels of LPS 
causing the release of mature leukocytes [3, 4]. Similarly to the CCR2 function, CXCR2
-/-
 
mice display moderate bone marrow retention why an antagonistic relationship between 
CXCR4 and CXCR2 has been suggested [68].  CXCR2 appear to have antagonistic effects of 
the bone marrow retaining action of CXCR4, heterologous desensitization via upregulation of 
GRK3 has been suggested as a possible mechanism by which bone marrow egress is 
achieved [68, 69].         
The human WHIM syndrome (wharts, hypogammaglobulinemi, infections and myelokatexis) 
is characterized by low levels of circulating leukocytes while bone marrow aspirates contain 
high levels of mature, mainly myeloid cells. WHIM is most commonly caused by mutations 
causing truncations in the cytoplasmatic tail of CXCR4 rendering it constitutively active 
preventing the phosphorylation necessary for receptor to internalization [70]. Interestingly, 
two patients with WHIM displaying wildtype CXCR4 gene have been found to have a defect 
in GRK3 expression again resulting in an inability to phosphorylate the cytoplasmatic tail of 
CXCR4 [71].  
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1.6.4 Extravasation 
 
Fig 2, Schematic overview of the  leukocyte adhesion cascade including slow rolling, cellular 
arrest and endothelial transmigration following gradient of chemokine concentration 
gradient. Adapted from Ley and colleagues 2007.Courtesy of Dr Malin Winerdal 
Extravasation from blood vessels to tissue is initiated when sensor cells express pro-
inflammatory cytokines which cause granules of preformed P-selectin in endothelial cell to 
fuse with the cell membrane and present on the cell surface within minutes of initiated 
immune response. E-selectin transcription begins simultaneously. Selectins on endothelial 
cells bind Lewis carbohydrate antigens like PSGL-1 on leukocytes which cause a loose 
association and rolling of leukocytes along the vessel due to shear flow bringing leukocytes 
and the endothelial surface in direct contact with each other. Intercellular adhesion 
molecules (ICAMs) on the endothelium may bind the leukocyte via integrins(CD11a-
c:CD18) more strongly to the vessel wall. Presence of chemokines and chemokine receptors 
such as CCL-8 and CXCR2 cause the cytoplasmic tail of the integrin to bind the actin 
skeleton of the leukocyte which induce conformational changes further strengthening the 
adhesion bringing the cell to a stop [72].  The firm adhesion to the vessel wall is followed by 
extravasation where the tight cell junction in the endothelium open and the intraluminal cell 
begin to traverse the endothelium and continue to migrate towards the chemokine 
concentration gradient on stromal cells and in the (ECM).  
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1.6.5 Lymph node homing 
The mode in which myeloid cells extravasate at sites of inflammation is very similar to the 
way naïve and some memory T cells enter lymph nodes. Naïve T-cells and memory T cells 
constantly traffic between different lymph nodes in search of their cognate antigen [73]. This 
is controlled by the same process as described above but the process is instead situated in the 
post capillary high endothelial venules (HEV) within secondary lymphoid organs such as the 
lymph nodes or spleen. Slow rolling is similarly induced by the lymphocyte (L-selectin, 
CD62L) together with ICAMs and integrins which finally cause adhesion and extravasation 
due to CCR7 expression on naive T-cells engaging CCL19 and or CCL21 [34]. Naïve and 
memory T-cells will, if they do not encounter their cognate antigen, leave the lymph node by 
down regulating CCR7 and instead migrate towards a gradient of S1P via the S1PR to the 
efferent lymphatic drainage to reenter blood circulation.       
Myeloid APCs migrate through the ECM toward a concentration gradient of chemokines and 
eventually reach the draining lymph node via the afferent lymphatics. Both the extravasation 
of the T-cell and the tissue migration of the myeloid cell are guided by the chemokine CCL21 
and CCL19 attracting cells expressing CCR7 [34]. Antigen presenting cells and T-cells meet 
in the T-cell zone of the lymph node. Here antigens are presented to naïve and memory T-
cells.    
Naïve B-cells, similar to T-cells need to enter the secondary lymphoid organs in order to 
establish the B-cell follicles. Naïve B-cell extravasate through the HEV and migrate toward a 
gradient of CCL13 using the CXCR5 receptor [74]. Similarly, follicular T helper cells (TFH) 
express both CCR7 and CXCR5 enabling trafficking to B-cell follicles [75]. 
1.6.6 Matrix migration 
Cells at the site of inflammation produce various cytokine and chemokines in the ECM which 
in turn diffuse in the surrounding tissue. The spread of chemokines form a concentration 
gradient with increasing chemokine concentration closer to the site of inflammation. How 
chemokine signaling cause cellular migration is still a very active research field but what is 
known is that the chemokines acting on chemokine receptors cause polarization of the 
migrating cell with active actin polymerization of the cytoskeleton in the leading edge of the 
cell causing protrusions in the cell membrane called lamellipodia [76]. At the other end of the 
cell, the actin cytoskeleton is instead degraded causing the cell to move forward.  
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 2 AIMS OF THE THESIS 
The aim of this thesis was to create an understanding of how the migratory system can be 
used to understand migratory function as well as phenotypic expression in different cell 
populations in different tissues. Additionally, the thesis aims to understand the interplay 
between pathogen and the immune system.  The specific aims for each study are 
presented below.  
 
 
Paper I. To investigate the levels of chemokine receptor expression on T-cells in bone 
marrow and peripheral blood from osteoarthritis patients and to compare the expression 
of these receptors with that of healthy peripheral blood. 
 
 
Paper II. To investigate the presences and level of chemokine receptor expression on 
monocyte and monocyte precursors during their development in human bone marrow.  
 
 
Paper III. To investigate the presence and function of Aire in myeloid DC subset and 
precursors in bone marrow and periphery of mice and men.  
 
 
Paper IV. To investigate whether the presence of parasite infection influence serological 
allergy tests and if this influence would be due to the presences of the carbohydrate 
epitope galactose –α-1,3-galactose. 
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 3 MATERIALS AND METHODS 
3.1 STUDY SUBJECTS 
Patients participating in studies were recruited via associated clinics. All participating study 
subjects were recruited after informed consent after ethical approval provided by local ethics 
committees according to the declaration of Helsinki.    
3.1.1 Cohorts 
Study subjects were included in one of the following cohorts. Patients undergoing elective 
arthroplastic surgery (paper I-III), patients with cat allergy or macroparasitic infection (paper 
IV).     
3.1.2 Tissues 
 In papers I, II and III, human bone marrow material was obtained from the proximal femur 
during elective hip arthroplasty surgery. Bone marrow material was transported at room 
temperature in cell medium RPMI 1640 with addition of 5000IU Heparin and Streptomycin 
and Methicillin. Bone marrow leukocytes where extracted using homogenization, filtering, 
density gradient centrifugation and ACK-lysis of remaining erythrocytes 
3.1.3 Healthy controls  
In paper I and III, blood from healthy donors was obtained as control.  
3.2 ANIMAL MODELS 
Study III contain work on a rodent model. Animals were housed and handled in accordance 
with permission from the local ethical board.   
3.2.1 AIRE deficient mice 
Aire 
-/-
 mice  were breed on C57BL/6 as previously described [40] and used together with age 
and sex matched littermates from heterozygote breeding as controls.   
3.3 FLOW CYTOMETERY  
Study I-II employed multicolor flow cytometry  
3.3.1 Staining protocol 
Single cells were suspended in phosphate-buffered saline with 5% autologous sera to avoid 
unspecific Fc-binding and stained with fluorophore coupled antibodies in different 
combinations. Isotype and fluorophore matched controls were used to define positive signal. 
Specific antibody panels can be found in the method section of respective study.   
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3.3.2 Sorting  
Sorting of cells were carried out in paper III to analyze population separately with PCR. 
Sorting was carried out by magnetic sorting either manually or using AutoMACS (Miltenyi, 
Biotech) and/or by FACS ARIA (BD Biosciences)  
3.4 PCR  
Total RNA was isolated (paper III) using TRIzol reagents(Invitrogen) and cDNA was 
synthesized by reverse transcription. Transcripts were amplified using specific primers on 
CFX96 Touch(Biorad) or iCycler IQ( Biorad).    
3.5 SEROLOGICAL TECHNIQUES 
3.5.1 Elisa 
An indirect Elisa technique was used (paper IV) to analyze levels of IgE specific for  rFel d 1, 
cat IgA and α-Gal. A 96-well plate was coated with 0,5μg of antigen blocked with BSA. 
100μl of serum was added  followed by rabbit anti-human IgE followed by conjugated anti-
rabbit with substrate.. 
3.5.2 ImmunoCAP 
Total and α-Gal specific IgE were analyzed in paper IV using the ImmunoCAP System 
(Phadia AB, Uppsala, Sweden), according to the manufacturer’s instructions. 
3.5.3 Antigen blocking 
Paper IV used antigen blockage with the ImmuoCAP system.  This included an overnight 
preincubation of sera α-Gal–HAS to block IgE specific for α-Gal. 
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 4 RESULTS AND DISCUSSION 
 
4.1 THE EGG OR THE CHICKEN -  WHAT IS OSTEOARTHROSIS? 
In paper I, we address a disorder which has not previously been commonly considered to be 
immunologically mediated.  Despite being one of the more common disorders affecting an 
ageing population, osteoarthrosis (OA) still remains an enigma. OA is more prevalent in 
weight bearing joint among the manual labour portion of the population. Thus, the notion that 
OA is a natural consequence of ageing is not outlandish. However, several studies have 
correlated OA not just to heavy labour but also to prolonged periods of physical inactivity, 
together with obesity and smoking. Likewise, previous trauma to the effected joint appears to 
be a common occurrence [77].   
Unfortunately, although the mechanical “wear and tear” etiology long since has been 
debunked, the theory still resonates among leymen and remarkably among many physicians. 
Several key events in the development of OA have been established were an increased 
protease activity lead to diminished cartilage which in turn cause reduced cartilage shock 
dampening effects and increase cortical bone density. 
The current treatment regime for OA consists of analgesia, physiotherapy and finally surgical 
replacement of the effected joint.  The degradation of the joint seldom become so severe that 
loss of function occurs (ie. arthrodesis or dislocation). Surprisingly, the state of joint 
destruction poorly correlates with the pain experienced by the patient. Substantial disability 
due to pain often precedes the radiological findings by years. It is therefore interesting to 
imagine that the disease primarily could be one of altered cartilage biology with increased 
propensity for inflammation with increased innervation and vascularisation rather than purely 
a cartilage metabolic disorder. 
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Fig 3. Percentage of memory and naïve T cells subset expressing CCR2 in peripheral blood 
from patients with OA (n=7) and healthy controls (n=9) together with OA bone marrow 
(n=7) derived T cells. Statistical analysis was performed using multiple paired t-test for OA 
derived patients and multiple unpaired t-test for comparison between healthy control and OA 
patient peripheral blood. Presented p-values are obtained using Benjamini-Hochberg 
correction for multiple comparisons. (p<0.05)=*, (p<0.01)=**,(p<0.001)=***     
Our findings in paper I suggest that patients with OA display an altered chemokine receptor 
function in the periphery compared to healthy controls. These findings could suggest an 
involvement of the adaptive immune system in disease progression although the elevated 
levels of CCR2 in patients OA peripheral T-cells might also suggest either a propensity of 
OA patients to express this chemokine alternately it could indicate an effect of 
pharmacological treatment [63, 64, 78]. As pain perception is central in disease pathology 
[79]  and in the selection of patients undergoing surgery one cannot exclude the possibility 
that increased propensity to express CCR2 might influence pain perception. This becomes 
even more intriguing considering the altered pain perception of CCR2 KO mice [80, 81]. As 
previously demonstrated, perioperative intraarticular opioid treatment significantly reduce 
post-surgical pain perception despite absence of peripheral opioid receptors [82, 83].     
Another aspect of these findings is the comparatively low levels of CCR2 in paired bone 
marrow. As we show in paper II, monocytes readily express CCR2 in bone marrow and as 
previously shown, also in the periphery [84]. CCR2 has been shown essential in bone marrow 
egress [3-5]. This could indicate that bone marrow T-cell are tissue resident without 
propensity to leave the bone marrow. During the study we have brushed upon several 
interesting and potentially useful therapeutic applications which would be of interest to 
investigate further. Along these lines there is a need for a deeper understanding of 
pharmacological effects on the often complex immune functions. 
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4.2 GLOBAL ASSESSMENT OF CHEMOKINE RECEPTOR EXPRESSION ON 
HUMAN MYELOID BONE MARROW PRECURSOR CELLS 
 
Due to the inaccessibility of human bone marrow, studies on the early developmental stages 
of hematopoetic cells is often limited to animal models alternately confined to studies in 
peripheral blood. Since we previously demonstrated that the chemokine receptor expression 
of peripheral monocyte populations remains stable and with little variability during steady 
state, we aimed to investigate steady state conditions of commonly expressed chemokine 
receptors in human bone marrow on myeloid precursor cells. Previous studies have shown 
how fully developed myeloid cells, primarily monocytes are stored in the bone marrow and 
released in response to peripheral signalling[3, 4, 6]. Given the multitude of myeloid progeny 
it is unclear when the division between the different myeloid cell compartments types occur. 
  
 
Fig 4 Spider chart displaying the average percentage of monoblasts, promonocytes and 
monocytes expressing of 19 chemokine receptors..   
 
In this paper we demonstrate how several chemokine receptors associated with mature 
monocyte subsets are also present on early developmental stages of myeloid precursor cells.   
To our knowledge, we show for the first time presence of bone marrow anchoring chemokine 
receptor CXCR7 in non-malignant CD34
+
 cells. Also surprising is the high prevalence of 
CXCR2 expressing bone marrow monocytes which in the periphery typically express CCR2. 
Expression of CCR2 is also present although at lower frequencies than seen in the periphery.   
Both CXCR2 and CCR2 has shown antagonistic function in regard to SDF-1 anchoring 
CXCR4 why this apparent receptor redundancy could serve to release cell upon peripheral 
demand.    
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Fig 5. Percentage of monocyte and myeloid progenitor cell expressing chemokine receptor 
CXCR2 and CCR2 in human bone marrow. Monoblasts were CD34
+
HLA-DR
+
CD14
-
, 
promonocytes CD34
-
, HLA-DR
+
, CD14
-
 and monocytes CD34
-
, HLA-DR
+
, CD14
+
. Statistical 
analysis was performed using multiple unpaired t-test. Presented p-values are obtained using 
Benjamini-Hochberg correction for multiple comparisons (p<0.05)=*, 
(p<0.01)=**,(p<0.001)=***     
 
Collectively these results forms a baseline chemokine receptor expression for myeloid 
precursor cell in human bone marrow and thereby provide insight into the developmental fate 
and characteristics of the myeloid linage and provide a comparative platform which could be 
used in phenotyping of myeloproliferative disorders and may aid in apheresis based 
treatments of chronic inflammatory disorders.  The study has potential for improvement, 
especially additional patient samples could, in parallel to flow cytometry, be analyzed for 
transcriptional markers for lineage commitment. Additionally, in vitro culturing of sorted 
cells could provide insights into phenotype stability and function.     
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4.3 TRANSCRIPTIONAL CONTROL OF AIRE IN THE PERIPHERY IS CONTROLLED 
BY IFN-GAMMA AND UNDER REGULATION OF GENES IMPORTANT FOR 
DEVELOPMENT OF DENDRITIC CELLS IN THE BONE MARROW  
 
In paper III, we investigate the role of the transcription factor Aire in myeloid bone marrow 
precursors. Previous studies have displayed how a subset of 33D1
+ 
murine mDCs found in 
spleen and human CD11c
+
 DCs in lymph nodes express the Aire transcription factor with a 
suggested function for peripheral tolerance [43]. Aire transcription factor has also been shown 
to be expressed in murine bone marrow why we wished to investigate when Aire expression 
occurred during the myeloid development of DCs. Similarly, we wished to confirm whether 
AIRE expression was similarly present in human bone marrow in general and in DC 
precursors in particular.  
The pre-DC subset in murine bone marrow was shown to contain Aire expression, albeit at 
lower levels than seen in wildtype whereas AIRE expression in human pre-DC subsets from 
bone marrow could not be confirmed. In addition, Aire
-/-
 deficient mice showed a diminished 
33D1
+
 population but had a sustained overall DC numbers indicating a potential 
developmental hindrance between the pre-DC subset and the fully mature splenic 33D1
+
. We 
therefore investigated levels of several transcription factors including RelB, IRF4 which have 
been shown to be important for the development of the 33D1
+ 
subset [85, 86]. Levels of RelB 
and IRF4 were reduced to approximately half of that of CD8
+
control DCs whereas 
33D1
+
displayed an induced expression of IRF8.    
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Fig 6. Relative expression of transcription factors in sorted CD8
+
 and 33D1
+
 DC subset from 
Aire
-/-
 mice and wildtype. Bars summarize mean and standard deviation of two independent 
experiments.   
IRF8 is also inducible by IFN-γ why wildtype 33D1+ DCs were stimulated with IFN-γ which 
abrogated Aire expression abruptly and remained supressed up to 14 hours . This was also 
seen in human peripheral myeloid DCs. Silencing of Aire has previously been shown to down 
regulate self-presentation by mTEC cells[25]. We therefore examined mRNA levels of the 
insulin gene Ins2 in peripheral 33D1
+
 DCs in response to IFN-γ which as expected followed 
that of Aire. To confirm that these finding were due to IFN-γ signalling the experiment was 
repeated in IFN-Rγ-/- mice. No response was noted but instead a fivefold increase of the Aire 
expression level compared to the basal level was noted. Thus, not only self-antigens such as 
insulin but also Aire itself seem to be regulated by IFN-γ signalling. 
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Fig 7. Relative mRNA expression of Aire and Ins2 expression measured at 2,4,6, 8 and 14 
hours with qRT-PCR after stimulation of 33D1
+
 DCs with IFN-γ.  
The presence of Aire expression in the periphery has previously contested [87] although an 
increasing body of evidence strongly suggest that Aire is expressed in the periphery and may 
also have functional properties[88-90]. This study show that Aire in the periphery have an 
impact on distribution of DC population and that TSA associates genes are down regulated in 
similar fashion to that of mTEC in response IFN-γ. However, it need to be further elucidated 
whether peripheral function of Aire impacts tolerance. 
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4.4 IMPACT ON IgE ALLERGY DIAGNOSTICS OF PARASITE INFECTION CAUSED 
BY CROSSREACTIVE IgE SPECIFIC FOR THE CARBOHYDRATE GALACTOSE-
α-1, 3-GALACTOSE 
Galactose-α-1,3-galactose (αGal) is a disaccharide present on some proteins as a result of 
posttranslational glycosylation in non-primate mammals. It is the product of the enzyme α-
1,3-galactosyltranferase whose gene is abrogated in primates including humans[91]. Instead, 
antibodies toward αGal is widely expressed presumably due to continuous expose through the 
gut microbiota [92] .   
The presence of preformed IgE antibodies towards the α-Gal epitope was first given clinical 
relevance during the introduction of Cetuximab, a monoclonal humanized mouse antibody 
directed toward epidermal growth factor receptor (EGFR) given to treat head and neck 
carcinomas. The preclinical trials which were performed in the northern USA suggested 
anaphylactic reactions in roughly 0.5-1% of treated patients. However, after the drug was 
introduced severely increased incidences of anaphylactic reactions were noted. The antigen 
binding domain was identified as the carbohydrate epitope Galactose-α-1,3-Galacose (α-Gal) 
[93, 94]. Many of the anaphylactic reaction often occurred during or shortly after the first 
infusion indicating the presences of preexisting antibodies. Indeed, researchers found up to a 
fifth of control subjects in some areas had preformed IgE antibodies to a-Gal [93]. The 
geographical distributions of the anaphylactic reactions suggested that some local pathogen or 
macroparasite caused the sensitization toward α-Gal. A high prevalence of cat allergy among 
patient with preformed IgE antibodies. In parallel, a new cat allergen (Fel d 5) was shown to 
have cross reactivity with another cat allergen were the α-Gal epitope was identified as the 
agent responsible for the cross reactivity [95, 96].  
As these studies together suggested a potential confounding factor during allergy diagnostics 
based in IgE toward animal dander among parasite infected patients, paper IV examines the 
presence of IgE antibodies towards αGal in patients with confirmed parasite infection. In 
parallel, cat allergic patient are similarly confirmed to have increased titers of αGal specific 
IgE. Based on the  IgE antibody titers we show how IgE specific for αGal and cat dander 
extract (CDE) as well as the α-Gal carrying allergen Fel d 5 correlate in the parasite infected 
patients indicating that anti-α-Gal IgE cause cross reactivity. The parasite infected patients 
did not however demonstrate convincing IgE titers nor titer correlation with IgE specific for 
the recombinant version of the major cat allergen (rFel d 1).     
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Fig 8. IgE titers among parasite infected patients (n=47) showing Spearman rank 
correlations between a towards cat dander extract (CDE) and A) purified cat allergen 5 (Fel 
d 5) (r = 0.75, P < 0.001), B) carbohydrate epitope α-Gal (r = 0.715, P < 0.001), C) 
recombinant cat allergen 1 (Fel d 1) (r = −0.20, P > 0.05).   
      
Similarly, 31 cat allergic patients were examined regarding their specific IgE titers towards 
αGal, Fel d 5, CDE and rFel d 1. The cat allergic patients did not convincingly display 
correlation in specific IgE titers towards CDE and Fel d 5 nor αGal . However, the titers of 
IgE specific for CDE and rFel d 1correlated among the cat allergic patients indicating they 
unlike the parasite infected were truly sensitized to cat allergens.       
 
 
 
Fig 9. IgE titers among cat allergic patients (n=31) showing Spearman rank correlations 
between a towards cat dander extract (CDE) and A) purified cat allergen 5 (Fel d 5) (r = 
0.10, P >0 .05), B) carbohydrate epitope α-Gal (r = −0.070, P >0 .05 ), C) recombinant cat 
allergen 1 (Fel d 1) (r = 0.70, P < 0.001). 
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To confirm that the IgE binding to CDE in the parasite infected patients were indeed due to 
IgE toward α-Gal we performed an inhibition assay. Sera from both patient groups were 
preincubated with the α-Gal epitope after which IgE titers towards CDE were assessed. As 
expected, the cat allergic patients still retained a high IgE titer towards CDE whereas parasite 
infected patients displayed a significant decrease in CDE specific IgE.  
 
 
Fig 10. CDE specific IgE titers in sera from cat allergic patients (n=5) and parasite infected 
patients (n=8) before and after α-Gal   
The use of serological analyses of allergen specific antibody titers has become widespread 
and is now commonly used by primary clinics as well as within veterinary medicine.  
Clinically, patient symptomology and history of allergic symptoms should remain the basis 
for diagnosis and if needed combined with skin prick test or controlled allergen challenge. 
However, these clinical tests are labour intensive and thereby expensive. It is therefore 
understandable that serological analyses have proven a useful tool for allergy diagnosis. 
However, serological sensitization analysis alone can be misguiding as shown in this paper 
and therefore need to be applied and interpreted with caution. 
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 5 CONCLUDING REMARKS AND FUTURE 
PERSPECTIVES 
Research within the field of immunology has undergone tremendous progress under the last 
decades. Many disorders which were previously thought to be of other origins have proven to 
be, at least in part, due to immunological processes. Recently, new cancer therapeutics based 
on immunological knowledge was granted the Nobel price. It is becoming ever more obvious 
that physicians in every clinical field need to deepen their knowledge of immunological 
processes in order to properly understand the disorders they are treating. This thesis has a 
wide scope concerning themes of immune migration, bone marrow development and 
tolerance as well as the interface between pathogens and the immune system. The study of 
migratory pattern in general and chemokine receptor expression in particular provide the 
physical backdrop and geography to immunological processes, thereby returning the field of 
immunology to bedside with a whole-body approach. Since the origin of immunology, most 
studies have been performed in peripheral blood which only provide a partial view of the 
underlying complexity why it is becoming ever more apparent that researcher need other 
sources of research material. Because of this, access to patients and patient derived material 
can be greatly improved trough collaboration between clinicians and researcher which benefit 
both researcher and clinicians and ultimately patients. This can only be achieved through an 
understanding of each other’s work environment, potential and limitations. 
In paper I we demonstrate that chemokine receptor expression in T cell populations differs 
between subsets and also between tissues. We were able to show that the expression of CCR2 
is greatly incremented in peripheral T cells of OA patients compared to that of healthy blood 
donors. This is interesting given that CCR2
-/-
 mice display an altered pain sensation with 
diminished neuropathic pain and that CCR2 display angiogenetic properties which is believed 
to contribute to disease progression in OA. We also prose a third line of inquiry which is that 
the opioids given to donors pose a potential for cross desensitization. This study therefore has 
several lines of inquiry which needs to be addressed in further studies.               
Paper II demonstrates how chemokine receptor expression vary during myeloid bone marrow 
development and show a gradual increase in CXCR2 and CCR2 which both have been shown 
to possess a switch function capable of releasing myeloid cells into the circulation upon 
demand. We demonstrate CXCR7 expression in the monoblast stage which to our knowledge 
is the first non-malignant cell type to do so. The study still has room for improvement and 
could greatly benefit additional comparative material as well as confirming analytical 
methods.   
Paper III confirms that Aire is expressed in peripheral 33D1 DCs. Furthermore, Aire 
expression was present in bone marrow from mice but we were unable to confirm AIRE 
expression in cells from human bone marrow. Based on findings of altered peripheral DC 
composition in Aire
-/-
mice we performed a series of stimulation studies suggesting that the 
transcription factor RelB is under control of Aire. We also show how Aire and related self-
antigen gene Ins2 are down regulated in response to the inflammatory cytokine IFN-γ.   
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In Paper IV we address the commonality of IgE responses between macroparasite infections 
and allergy. We demonstrate how macroparasitic infections influence the serology of patients 
which renders them sensitized to cat dander. We also show that the cross reactivity is 
dependent on the carbohydrate αGal. We display how true cat allergic patients can be 
distinguished from patients with macroparasitic infections using a component resolution 
based serology analysis.   
This study has been followed by others suggesting that the sensitization toward αGal could be 
achieved through tick bite and that sensitization to αGal may result in red meat allergy. The 
serology aspect is interesting although no substantial effort has been made to understand how 
IgE production towards an antigen is achieved which could present an interesting line of 
research. Also, the field of parasitology has due to it nature as third world disorder not gained 
as much interest nor funding as it otherwise should. Since macroparasites truly are masters of 
their environment it would be of great interest to further understand how they avoid immune 
detection and as in some cases gain tolerance from the immune system.   
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